FSR vs TSHA
FSR (FSR) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
FSR (FSR) common stock.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
FSR does not have a complete income-statement cache yet.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
TSHA currently screens at market cap $640.7M.
Not investment advice. Open the FSR and TSHA stock pages for the full models.
Not investment advice.